Abbott, Medtronic to Withdraw Stents From Indian Market
Medtronic and Abbott are withdrawing select high-value stents from the Indian market following cost caps imposed by the Indian National Pharmaceutical Pricing Authority, according to a Financial Express report.
Medtronic has filed to remove its Resolute Onyx stent from the market, while Abbott filed to remove both its Absorb and Alpine stents.
Last year, Indian NPPA imposed price restrictions which set limits on the costs of metal, drug eluting and bioresorbable stents. The regulatory body also set limits on trade margins, discounts and other promotions used on higher-end products.
Medtronic has filed to remove its Resolute Onyx stent from the market, while Abbott filed to remove both its Absorb and Alpine stents.
Last year, Indian NPPA imposed price restrictions which set limits on the costs of metal, drug eluting and bioresorbable stents. The regulatory body also set limits on trade margins, discounts and other promotions used on higher-end products.